STAT3 and ovarian cancer: In addition, I-BET151 reduces the migration and invasion of EOC cells by inhibiting the Stat3 signaling pathway and downregulating ZEB2 and N-cadherin, which also inhibits tumor metastasis in the abdominal metastasis model of ovarian cancer (30, 53).